• Exagen Inc focuses on autoimmune diagnostics as investors watch strategy AD HOC NEWS Tue, 07 Jul 2026 18:43:38 GMT
• enterprise value to ebit forward of exagen inc. – nasdaq:xgn TradingView Mon, 29 Jun 2026 17:23:48 GMT
• enterprise value to revenue forward of exagen inc. – nasdaq:xgn TradingView Fri, 26 Jun 2026 21:35:21 GMT
• Exagen sets dates for second-quarter results, shares watched around Nasdaq listing AD HOC NEWS Thu, 25 Jun 2026 20:21:34 GMT
• xgn initiates coverage on exagen -- roth capital assigns buy rat GuruFocus Thu, 25 Jun 2026 11:49:27 GMT
• XGN Q1 2026 Earnings: EPS Beat Drives Positive Stock Movement - Strong Earnings Momentum dars.gov.et Thu, 25 Jun 2026 07:00:00 GMT
• exagen inc (xgn) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• exagen (xgn) gains buy rating with $8 price target from analyst GuruFocus Thu, 25 Jun 2026 05:11:37 GMT
• Form 4 Exagen Inc For: 24 June By Investing.com Investing.com Nigeria Wed, 24 Jun 2026 18:08:03 GMT
• Exagen (XGN) Gains Buy Rating with $8 Price Target from Analyst GuruFocus Wed, 24 Jun 2026 07:00:00 GMT
• roth starts exagen at buy, notes biomarker testing outperformance TipRanks Wed, 24 Jun 2026 07:00:00 GMT
• exagen inc (xgn) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• Exagen (XGN) director Frank Stokes receives 37,500 stock options at $4.31 Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Exagen lands permit for 15-MW solar project in England | Solar Power News Renewables Now Mon, 22 Jun 2026 07:00:00 GMT
• Exagen (XGN) director Scott Kahn receives 37,500 stock options grant Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Exagen (XGN) director granted 37,500 stock options at $4.31 strike Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• exagen stock - sunday background on autoimmune diagnostics specialist AD HOC NEWS Sun, 21 Jun 2026 17:41:53 GMT
• exagen advances use of new ra biomarkers to refine patient risk assessment Traders Union Fri, 19 Jun 2026 14:10:13 GMT
• XGN Q1 2026 Earnings: EPS Surprises with 15.15% Beat; Stock Gains 6.82% - EPS Consistency Score dars.gov.et Fri, 19 Jun 2026 07:00:00 GMT
• exagen (xgn) stock draws fresh price target split after analysts trim targets Yahoo Finance Fri, 19 Jun 2026 04:33:00 GMT
• Exagen (XGN) Stock Draws Fresh Price Target Split After Analysts Trim Targets Yahoo Finance Thu, 18 Jun 2026 07:00:00 GMT
• exagen inc (xgn) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• exagen inc (xgn) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• exagen inc (xgn) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:31:58 GMT
• exagen inc (xgn) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 20:59:39 GMT
• exagen inc (xgn) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 20:53:43 GMT
• exagen inc (xgn) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 10:17:48 GMT
• exagen inc (xgn) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 09:53:22 GMT
• exagen inc (xgn) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 09:50:50 GMT
• Exagen Inc (XGN) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey Wed, 17 Jun 2026 09:46:56 GMT
• exagen inc (xgn) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• exagen inc. (xgn) q1 2026 earnings: adjusted loss narrows, stock gains in aftermath - profit growth outlook newsline.com Thu, 11 Jun 2026 18:40:07 GMT
• Exagen wins planning permit for 50-MW solar park with BESS in England Renewables Now Thu, 11 Jun 2026 07:00:00 GMT
• Exagen Secures Planning Approval for 50 MW Solar and Battery Storage Project in England SolarQuarter Thu, 11 Jun 2026 07:00:00 GMT
• Developer appeals rejection of 230-acre solar farm that could power 11,300 homes North Norfolk News Thu, 11 Jun 2026 07:00:00 GMT
• exagen shareholders approve directors, auditor and pay package The Globe and Mail Wed, 10 Jun 2026 07:00:00 GMT
• exagen shareholders approve directors, auditor and pay package TipRanks Tue, 09 Jun 2026 20:35:38 GMT
• exagen (nasdaq: xgn) shareholders approve directors, auditor and say-on-pay Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• xgn q1 2026 earnings: eps beats estimates despite stock decline - revenue surprise history newsline.com Tue, 09 Jun 2026 04:43:13 GMT
• XGN Q1 2026 Earnings: EPS Beats Estimates Despite Stock Decline - Adjusted Earnings Analysis dars.gov.et Mon, 08 Jun 2026 07:00:00 GMT
• exagen inc. q1 2026 earnings: eps surprise lifts but revenue disclosure gap weighs on shares - earnings sentiment score newsline.com Sat, 06 Jun 2026 11:34:04 GMT
• exagen inc. (xgn) plunges 9.4% – key support levels in focus after sharp selloff - volume nodes newsline.com Fri, 05 Jun 2026 07:00:00 GMT
• Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• exagen study shows lupus test identifies 25% more patients Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• lupus test used on 1m patients finds cases routine lab work misses Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• record revenue growth and higher test pricing keep exagen (xgn) in focus despite ongoing losses MSN Fri, 29 May 2026 14:59:27 GMT
• how much upside is left in exagen (xgn)? wall street analysts think 73.05% MSN Fri, 29 May 2026 10:06:21 GMT
• Exagen Inc. (XGN) Q1 2026 Earnings: EPS Beats Estimates by 15.15%, Revenue Details Withheld, Stock Declines - Debt Analysis Report... dars.gov.et Fri, 29 May 2026 07:00:00 GMT
• how much upside is left in exagen (xgn)? wall street analysts think 73.05% Yahoo Finance Thu, 28 May 2026 07:00:00 GMT
• parian ultreia reports 5.3% stake in exagen (nasdaq: xgn) Stock Titan Wed, 27 May 2026 07:00:00 GMT
• exagen inc. q1 2026 earnings: eps beat surprises, but revenue details absent - geographic revenue trends newsline.com Tue, 26 May 2026 07:00:00 GMT
• exagen inc. (xgn) holds steady near support amid low volatility - liquidity sweep The Legal Advocate Tue, 26 May 2026 03:33:08 GMT
• Exagen Inc. (XGN) Holds Steady Near Support Amid Low Volatility - Social Sentiment dars.gov.et Mon, 25 May 2026 07:00:00 GMT
• XGN Q1 2026 Earnings: EPS Beat Highlights Cost Discipline Amid Revenue Uncertainty - Buyback Announcement Report dars.gov.et Mon, 25 May 2026 07:00:00 GMT
• exagen inc. (xgn) inches lower as shares test key support near $4.05 - descending triangle newsline.com Mon, 25 May 2026 07:00:00 GMT
• exagen inc. (xgn) q1 2026 earnings: narrower-than-expected loss drives positive surprise - net profit margin newsline.com Sat, 23 May 2026 07:00:00 GMT
• earnings call transcript: exagen inc. beats q1 2026 expectations, stock surges Investing.com Nigeria Fri, 22 May 2026 15:36:23 GMT
• exagen inc stock (us30063k1051): 13g filing shows 9.9% stake Ad-hoc-news.de Thu, 21 May 2026 07:00:00 GMT
• exagen earnings call highlights growth amid headwinds The Globe and Mail Thu, 21 May 2026 07:00:00 GMT
• exagen (xgn) holder jorey chernett reports 2.41m shares, 9.9% Stock Titan Wed, 20 May 2026 07:00:00 GMT
• exagen stock (us30063k1051): autoimmune testing specialist updates investors with latest lupus data AD HOC NEWS Tue, 19 May 2026 07:00:00 GMT
• exagen (xgn) reports strong q1 2026 — revenue $n/a, eps beats - earnings deceleration risk newsline.com Mon, 18 May 2026 07:00:00 GMT
• exagen reaffirms $70m-$73m 2026 revenue guidance as it targets $600-$650 asp over time MSN Sun, 17 May 2026 19:14:48 GMT
• earnings call transcript: exagen inc. beats q1 2026 expectations, stock surges Investing.com Nigeria Sun, 17 May 2026 00:28:37 GMT
• record revenue growth and higher test pricing keep exagen (xgn) in focus despite ongoing losses MSN Sun, 17 May 2026 00:27:21 GMT
• why exagen (xgn) just dropped -4.55% — what to watch 2026-05-15 - ratio spread trade newsline.com Fri, 15 May 2026 07:00:00 GMT
• record revenue growth and higher test pricing keep exagen (xgn) in focus despite ongoing losses MSN Thu, 14 May 2026 16:26:08 GMT
• the exagen inc. (nasdaq:xgn) first-quarter results are out and analysts have published new forecasts Yahoo Finance Thu, 14 May 2026 07:00:00 GMT
• exagen inc. (nasdaq:xgn) just released its first-quarter results and analysts are updating their estimates Sahm Thu, 14 May 2026 07:00:00 GMT
• exagen inc. (nasdaq:xgn) q1 2026 earnings call transcript Insider Monkey Wed, 13 May 2026 12:20:44 GMT
• exagen earnings call highlights growth amid key risks The Globe and Mail Wed, 13 May 2026 07:00:00 GMT
• ccorf maintains exagen(xgn.us) with buy rating, maintains target price $8 富途牛牛 Tue, 12 May 2026 13:35:01 GMT
• btig maintains exagen(xgn.us) with buy rating, cuts target price to $8 富途牛牛 Tue, 12 May 2026 11:32:00 GMT
• exagen earnings beat by $0.05, revenue topped estimates by investing.com Investing.com South Africa Tue, 12 May 2026 10:00:22 GMT
• exagen inc (xgn) q1 2026 earnings call highlights: record revenue and strategic growth amid challenges GuruFocus Tue, 12 May 2026 08:50:28 GMT
• td cowen maintains exagen(xgn.us) with buy rating, cuts target price to $8 富途牛牛 Tue, 12 May 2026 07:40:55 GMT
• exagen inc stock (us30063k1051): q1 revenue hits record $17.3m, up 12% AD HOC NEWS Tue, 12 May 2026 07:00:00 GMT
• exagen stock price target lowered to $8 by btig on valuation Investing.com Tue, 12 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: exagen (xgn) and liquidia technologies (lqda) The Globe and Mail Tue, 12 May 2026 07:00:00 GMT
• exagen inc. 2026 q1 - results - earnings call presentation (nasdaq:xgn) 2026-05-12 Seeking Alpha Tue, 12 May 2026 07:00:00 GMT
• exagen wins buy rating on strong q1 beat, improving fundamentals and clear path to ebitda breakeven TipRanks Tue, 12 May 2026 07:00:00 GMT
• exagen (xgn) reports record q1 revenue of $17.3 million, up 12% year-over-year GuruFocus Tue, 12 May 2026 07:00:00 GMT
• exagen: buy rating reiterated as strong execution and growth outlook support unchanged $8 price target TipRanks Tue, 12 May 2026 07:00:00 GMT
• exagen’s risk profile remains unchanged: stable yet persistent exposures keep investors on alert TipRanks Tue, 12 May 2026 06:10:35 GMT
• exagen reaffirms $70m-$73m 2026 revenue guidance as it targets $600-$650 asp over time MSN Tue, 12 May 2026 05:43:28 GMT
• is exagen (xgn) 30.9% overvalued after q1 2026 earnings? eps -0. GuruFocus Mon, 11 May 2026 22:13:58 GMT
• exagen earnings beat by $0.05, revenue topped estimates Investing.com Nigeria Mon, 11 May 2026 20:08:48 GMT
• td cowen maintains exagen(xgn.us) with buy rating, cuts target price to $8 Moomoo Mon, 11 May 2026 19:31:00 GMT
• exagen (nasdaq:xgn) issues earnings results, beats estimates by $0.07 eps MarketBeat Mon, 11 May 2026 16:31:46 GMT
• xgn: record revenue, higher asp, and strong test volume growth drive positive 2026 outlook TradingView Mon, 11 May 2026 14:44:40 GMT
• xgn: q1 2026 revenue up 12% to $17.3m, with margin and asp gains; guidance reaffirmed TradingView Mon, 11 May 2026 13:58:44 GMT
• exagen inc. (nasdaq:xgn) soars on q1 2026 earnings beat as record revenue and narrowed loss fuel pre-market rally ChartMill Mon, 11 May 2026 13:22:12 GMT
• exagen beats q1 revenue estimates, reaffirms 2026 guidance TradingView Mon, 11 May 2026 12:09:41 GMT
• xgn: q1 2026 delivered record revenue, improved margins, and reaffirmed strong full-year guidance TradingView Mon, 11 May 2026 12:04:22 GMT
• brief-exagen inc. q1 revenue usd 17.306 million vs. ibes estimate usd 16.4 million TradingView Mon, 11 May 2026 12:00:49 GMT
• Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• Record Revenue Growth and Higher Test Pricing Keep Exagen (XGN) in Focus Despite Ongoing Losses Yahoo Finance Mon, 11 May 2026 07:00:00 GMT
• Exagen Hits Record Q1 Revenue, Signals Path to Profitability BriefGlance Mon, 11 May 2026 07:00:00 GMT
• Exagen Inc. Reports Record Q1 2026 Revenue and AVISE CTD Average Selling Price Minichart Mon, 11 May 2026 07:00:00 GMT
• autoimmune test maker exagen lifts prices, posts record $17.3m quarter Stock Titan Mon, 11 May 2026 07:00:00 GMT
• exagen (xgn) posts record q1 2026 revenue and higher avise ctd pricing Stock Titan Mon, 11 May 2026 07:00:00 GMT
• exagen (xgn) achieves strong q1 revenue exceeding expectations GuruFocus Mon, 11 May 2026 07:00:00 GMT
• exagen (nasdaq: xgn) grows q1 2026 revenue to $17.3m but remains loss-making Stock Titan Mon, 11 May 2026 07:00:00 GMT
• exagen inc (xgn) q1 2026 earnings call highlights: record revenue and strategic growth amid ... by gurufocus Investing.com Canada Mon, 11 May 2026 07:00:00 GMT
Exagen Inc(NASDAQ:XGN) 
Exagen Inc. develops and commercializes various testing products based on its Cell-Bound Complement Activation Products technology under the AVISE brand in the United States. It enables rheumatologists to enhance care for patients through the diagnosis, prognosis, and monitoring of complex autoimmun...
Website: http://www.exagen.com
Founded: 2002
IPO Price: $14 (Sep 19, 2019)
Full Time Employees: 153
CEO: Fortunato Ron Rocca
Sector: Healthcare
Industry: Diagnostics & Research